True Corporation has partnered with OYMotion to develop Neuro AI technology aimed at improving physical therapy and rehabilitation, the company said on Monday.
The collaboration, led by True’s Research and Innovation Center, integrates Brain-Computer Interface (BCI) technology with artificial intelligence and a data platform to enable patients to control smart devices or prosthetics through neural signals transmitted over True’s network.
The system translates brain activity into commands, stimulating neural pathways to trigger muscle movement. The approach is designed to support cognitive retraining and accelerate recovery compared with conventional therapy, particularly for stroke patients and those with paralysis or mobility impairments.
True said the technology is being piloted with patients at leading hospitals in Thailand to validate clinical outcomes. If successful, it could be scaled across the public health system.
The initiative also aims to address shortages of specialised physical therapists and reduce long-term rehabilitation costs, which remain key barriers to continuous care.
According to True, the platform combines OYMotion’s neural sensing and signal decoding capabilities with its own digital ecosystem, enabling real-time transmission of brainwave and muscle data. This allows robotic devices or prosthetics to perform movements that closely mimic natural human motion.
Ekaraj Panjavinin, head of Research and Innovation at True Corporation, said the partnership reflects the company’s strategy to develop technologies that improve quality of life.
“Combining Thai medical expertise with world-class NeuroTech will be the cornerstone for transforming Thailand’s rehabilitation healthcare system into a leading regional hub,” he said.
Ni Hualiang, founder and CEO of OYMotion, said the company focuses on affordable rehabilitation solutions using neural sensing and AI-driven signal recognition.
“Together, we aim to transform traditional physical therapy into a smarter, more seamless experience and set a new standard for rehabilitation,” he said.
True said the technology is expected to benefit patients through faster recovery and greater independence, while enabling doctors to tailor treatment using brain function data. Hospitals could also expand access to rehabilitation services while maintaining care standards.
If widely adopted, the companies said the initiative could help position Thailand as a regional centre for NeuroTech innovation.
